Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors
Clinical trial NCT02367352 · TERMINATED
Trial details
- NCT number
- NCT02367352
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-19
- Primary completion
- 2017-05-23
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.